BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26480304)

  • 1. Skincare products containing low concentrations of formaldehyde detected by the chromotropic acid method cannot be safely used in formaldehyde-allergic patients.
    Hauksson I; Pontén A; Gruvberger B; Isaksson M; Engfeldt M; Bruze M
    Br J Dermatol; 2016 Feb; 174(2):371-9. PubMed ID: 26480304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formaldehyde in cosmetics in patch tested dermatitis patients with and without contact allergy to formaldehyde.
    Hauksson I; Pontén A; Isaksson M; Hamada H; Engfeldt M; Bruze M
    Contact Dermatitis; 2016 Mar; 74(3):145-51. PubMed ID: 26696132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten-year trends in contact allergy to formaldehyde and formaldehyde-releasers.
    Fasth IM; Ulrich NH; Johansen JD
    Contact Dermatitis; 2018 Nov; 79(5):263-269. PubMed ID: 30079600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formaldehyde and formaldehyde releasers: how much avoidance of cross-reacting agents is required?
    Herbert C; Rietschel RL
    Contact Dermatitis; 2004 Jun; 50(6):371-3. PubMed ID: 15274729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contact dermatitis caused by preservatives.
    Yim E; Baquerizo Nole KL; Tosti A
    Dermatitis; 2014; 25(5):215-31. PubMed ID: 25207684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formaldehyde exposure and patterns of concomitant contact allergy to formaldehyde and formaldehyde-releasers.
    Lundov MD; Johansen JD; Carlsen BC; Engkilde K; Menné T; Thyssen JP
    Contact Dermatitis; 2010 Jul; 63(1):31-6. PubMed ID: 20597931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preservatives as important etiologic factors of allergic contact dermatitis].
    Kręcisz B; Chomiczewska-Skóra D; Kieć-Świerczyńska M
    Med Pr; 2015; 66(3):327-32. PubMed ID: 26325045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preservatives in cosmetics: reactivity of allergenic formaldehyde-releasers towards amino acids through breakdown products other than formaldehyde.
    Kireche M; Gimenez-Arnau E; Lepoittevin JP
    Contact Dermatitis; 2010 Oct; 63(4):192-202. PubMed ID: 20731691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cosmetic preservative labelling on the Thai market.
    Bunyavaree M; Kasemsarn P; Boonchai W
    Contact Dermatitis; 2016 Apr; 74(4):217-21. PubMed ID: 26799537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can an imidazolidinyl urea-preserved corticosteroid cream be safely used in individuals hypersensitive to formaldehyde?
    Isaksson M; Gruvberger B; Goon AT; Bruze M
    Contact Dermatitis; 2006 Jan; 54(1):29-34. PubMed ID: 16426291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formaldehyde-releasers in cosmetics: relationship to formaldehyde contact allergy. Part 2. Patch test relationship to formaldehyde contact allergy, experimental provocation tests, amount of formaldehyde released, and assessment of risk to consumers allergic to formaldehyde.
    de Groot A; White IR; Flyvholm MA; Lensen G; Coenraads PJ
    Contact Dermatitis; 2010 Jan; 62(1):18-31. PubMed ID: 20136876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergic contact dermatitis to 2-bromo-2-nitropropane-1,3-diol in a hydrophilic ointment.
    Storrs FJ; Bell DE
    J Am Acad Dermatol; 1983 Feb; 8(2):157-70. PubMed ID: 6219135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contact allergy to methylchoroisothiazolinone/methylisothiazolinone (MCI/MI): findings from a contact dermatitis unit.
    Maio P; Carvalho R; Amaro C; Santos R; Cardoso J
    Cutan Ocul Toxicol; 2012 Jun; 31(2):151-3. PubMed ID: 22050127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patch-test reactions to formaldehydes, bioban, and other formaldehyde releasers.
    Anderson BE; Tan TC; Marks JG
    Dermatitis; 2007 Jun; 18(2):92-5. PubMed ID: 17498414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative patch and repeated open application testing in methyldibromo glutaronitrile-sensitive patients.
    Schnuch A; Kelterer D; Bauer A; Schuster Ch; Aberer W; Mahler V; Katzer K; Rakoski J; Jappe U; Krautheim A; Bircher A; Koch P; Worm M; Löffler H; Hillen U; Frosch PJ; Uter W
    Contact Dermatitis; 2005 Apr; 52(4):197-206. PubMed ID: 15859992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergic contact dermatitis in preservatives: current standing and future options.
    Deza G; Giménez-Arnau AM
    Curr Opin Allergy Clin Immunol; 2017 Aug; 17(4):263-268. PubMed ID: 28548971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in formaldehyde and formaldehyde-releaser contact allergies as compared with market exposure in Thailand.
    Boonchai W; Pruksaeakanan C; Wongdama S; Bunyavaree M; Kumpangsin T; Chaiyabutr C
    Contact Dermatitis; 2023 Jan; 88(1):18-26. PubMed ID: 35838492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of positive patch test reactions to lanolin: A ROAT study.
    Uldahl A; Engfeldt M; Svedman C
    Contact Dermatitis; 2021 Jan; 84(1):41-49. PubMed ID: 32844454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methyldibromoglutaronitrile in rinse-off products causes allergic contact dermatitis: an experimental study.
    Jensen CD; Johansen JD; Menné T; Andersen KE
    Br J Dermatol; 2004 Jan; 150(1):90-5. PubMed ID: 14746621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contact allergy to and allergic contact dermatitis from formaldehyde and formaldehyde releasers: A clinical review and update.
    Goossens A; Aerts O
    Contact Dermatitis; 2022 Jul; 87(1):20-27. PubMed ID: 35229319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.